Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
02/2003
02/11/2003US6517809 Using a breath test; vehicle containing a sugar is powder or granules, coating vehicle with an isotope-labeled urea and encapsulating the coated vehicle in gelatin
02/11/2003CA2320129C Suspension aerosol formulations
02/11/2003CA2176223C Fenbendazole formulations
02/11/2003CA2156905C Powdery pharmaceutical preparation and method of manufacturing same
02/11/2003CA2151564C Monomeric insulin analog formulations
02/11/2003CA2110376C Pharmaceutical enema preparation
02/11/2003CA2102606C Compositions for the treatment of chronic fatigue syndrome
02/08/2003CA2354932A1 Topical treatment of pain and to promote healing
02/06/2003WO2003010298A1 'probiotic lactobacillus salivarius strains
02/06/2003WO2003010297A1 Probiotic bifidobacterium strains
02/06/2003WO2003010281A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
02/06/2003WO2003010188A1 Production of high molecular mass lectins
02/06/2003WO2003009881A2 Novel targeted delivery system for bioactive agents
02/06/2003WO2003009877A1 Topical pharmaceutical formulation
02/06/2003WO2003009874A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules
02/06/2003WO2003009868A1 Antigenic compositions
02/06/2003WO2003009846A1 Novel substituted benzimidazole dosage forms and method of using same
02/06/2003WO2003009842A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
02/06/2003WO2003009831A1 Compositions containing sustained-release fine grains for tablets quickly disintegrable in the oral cavity and process for producing the same
02/06/2003WO2003009830A1 Coated granules of allylamine- or benzylamine-anti-mycotics
02/06/2003WO2003009829A2 Antiemetic, anti-motion sustained release drug delivery system
02/06/2003WO2003009817A2 Stable lyophilized pharmaceutical formulation of igg antibodies
02/06/2003WO2003009815A2 Compositions and methods for modulating blood-brain barrier transport
02/06/2003WO2003009802A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
02/06/2003WO2003009800A1 Sustained-release therapeutic bioadhesive systems
02/06/2003WO2003009784A1 Ophthalmic drug delivery device
02/06/2003WO2002089773A3 Pharmaceutical compositions comprising cyclosporin
02/06/2003WO2002085951A3 Water soluble, randomly substituted partial n-, partial o-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
02/06/2003WO2002085337B1 Micellar drug delivery systems for hydrophobic drugs
02/06/2003WO2002078605A3 Premixed amiodarone parenteral solution and method for making the same
02/06/2003WO2002070029A3 Porous beta-tricalcium phosphate granules and methods for producing same
02/06/2003WO2002060950A3 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
02/06/2003WO2002049666A3 Mycoplasma hyopneumoniae bacterin vaccine
02/06/2003WO2002040545A9 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point
02/06/2003WO2002030470A9 Methods and compositions for nucleic acid delivery
02/06/2003WO2002021996A3 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
02/06/2003WO2002020722A3 Methods and compositions for in vitro targeting
02/06/2003WO2002019963A3 Synthetic erythropoiesis stimulating proteins
02/06/2003WO2002016602A3 Compositions and methods for the diagnosis and treatment of tumor
02/06/2003WO2002013870A3 Formulation for administering therapeutic lipophilic molecules
02/06/2003WO2002002095A3 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin
02/06/2003WO2001091725A9 Biologically useful polyphosphates
02/06/2003US20030028025 Pediatric formulation of gatifloxacin
02/06/2003US20030028000 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders
02/06/2003US20030027995 Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
02/06/2003US20030027940 Biodegradable copolymers linked to segment with a plurality of functional groups
02/06/2003US20030027929 Heterofunctional polyethylene glycol and polyethylene oxide, process for their manufacture
02/06/2003US20030027868 Aminoacetalization of camphor by reacting with NH4OH and suspending product in NaCl; preparation having a basic pH is then neutralised with nitric acid; product is an analogue of human cytokines
02/06/2003US20030027858 Emulsion vehicle for poorly soluble drugs
02/06/2003US20030027841 Percutaneously applicable preparation and suppository containing an antidementia medicament
02/06/2003US20030027833 Compositions and delivery systems for administration of a local anesthetic agent
02/06/2003US20030027818 Treatment of cancers
02/06/2003US20030027816 Oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate salt or solvate; useful for treatment of psychotic patients
02/06/2003US20030027811 Compositions containing alpha-2-adrenergic agonist components
02/06/2003US20030027804 Administering to the mammal a menopause disorder effective amount of an orally deliverable pharmaceutically- acceptable sex hormone binding globulin synthesis inhibiting agent, and at least one of a non-orally deliverable steroids
02/06/2003US20030027791 Composition and method for reducing adverse interactions between phenothiazine derivatives and plasma using cyclodextrins
02/06/2003US20030027790 Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems
02/06/2003US20030027786 Lipase inhibiting composition
02/06/2003US20030027784 Biologically tolerated low molecular weight polyethylenimines
02/06/2003US20030027780 For transporting therapeutic, prophylactic and diagnostic agents across mucosal membranes such as gastrointestinal, buccal, nasal, rectal and vaginal
02/06/2003US20030027773 Protein-polycation conjugates
02/06/2003US20030027772 Composition containing at least one inhibitor of the enzyme 3-beta-HSD
02/06/2003US20030027770 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
02/06/2003US20030027748 For therapy of diabetes
02/06/2003US20030027338 Mutant adenovirus genome for use as vector in genetic engineering
02/06/2003US20030027336 Process of entrapping genetic materials in ultra-low size nanoparticles of inorganic compounds to form non-viral carriers
02/06/2003US20030027311 Recombinant anti-tumor RNAse
02/06/2003US20030027299 Biochemical conjugate for use in the treatment or prevention of stroke, heart defect, veinous thrombosis, sepsis and embolism
02/06/2003US20030027151 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of bone disorders
02/06/2003US20030026862 (+)-Cycloolivil as antioxidant obtained from a new natural source namely stereospermum personatum
02/06/2003US20030026850 Penetration of blood, brain barrier; transdermal drug delivery; mixing with dinitroamide compound
02/06/2003US20030026841 Compositions and methods for drug delivery using pH sensitive molecules
02/06/2003US20030026840 Immobilized into polyoxyethylene glycol
02/06/2003US20030026839 Melt-extrusion multiparticulates
02/06/2003US20030026832 Controlling particle size
02/06/2003US20030026829 Analgesic patch
02/06/2003US20030026820 Use of a compositon containing an effective quantity of at least one ion chelating agent for increasing the tolerance threshold of a sensitive or intolerant skin
02/06/2003US20030026819 Protective coating for skin
02/06/2003US20030026805 Genetic engineering; monoclonal antibody grafted to tumor necrosis factor
02/06/2003US20030026798 In situ dissolving of deposits
02/06/2003US20030026792 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
02/06/2003US20030026766 Administering by inhalation
02/06/2003US20030026764 Administering antibodies; anticancer agents
02/06/2003CA2493596A1 Novel targeted delivery system for bioactive agents
02/06/2003CA2455602A1 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
02/06/2003CA2454920A1 Antigenic compositions
02/06/2003CA2454803A1 Probiotic bifidobacterium strains
02/06/2003CA2454150A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
02/06/2003CA2453106A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules
02/06/2003CA2450073A1 Compositions and methods for modulating blood-brain barrier transport
02/06/2003CA2419089A1 Composition comprises sustained-release fine particles for quick-disintegrating tablets in the buccal cavity and manufacturing method thereof
02/05/2003EP1281401A2 The medical effect of Jojoba oil
02/05/2003EP1281400A2 Pharmaceutical compositions containing ascomycin derivatives
02/05/2003EP1281398A1 Dermal compositions containing coenzyme q as the active ingredient
02/05/2003EP1281397A1 Orally administered controlled drug delivery system providing temporal and spatial control
02/05/2003EP1280923A2 14094, a human trypsin family member and uses thereof
02/05/2003EP1280921A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
02/05/2003EP1280908A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene 2
02/05/2003EP1280907A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
02/05/2003EP1280906A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
1 ... 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 ... 1712